qEEG (Initial Brain Map)

Long-term substance use leaves measurable footprints on brain electrical activity, and qEEG (quantitative electroencephalogram) is one of the few tools that visualizes them objectively. At RECO Island in Boynton Beach we use qEEG to confirm what subjective symptoms only suggest — that years of alcohol, opioid, or stimulant use have shifted oscillation patterns in the frontal lobes, the limbic system, and the default mode network. The map gives the clinical team something concrete to track, helps explain to patients why concentration and emotional regulation are still hard weeks into sobriety, and informs aftercare planning around neurofeedback, structured therapy, or psychiatric medication.

Chronic heavy alcohol use is associated with frontal-lobe hypoactivity, increased frontal slow waves (delta and theta), and reduced beta activity in regions tied to executive function and impulse control — the qEEG correlate of impaired judgment and craving control. Long-term opioid use often shows reduced alpha amplitude and altered functional connectivity in pain-processing and reward networks. Stimulant use tends to drive frontal hyperarousal that takes weeks to settle. None of these patterns is permanent on day one of sobriety. Repeat qEEG several weeks into recovery typically shows partial normalization, which is reassuring data for both the patient and the clinical team.

We do not scan patients in active intoxication or in the most acute hours of withdrawal — the readings are unreliable and the patient cannot tolerate the cap-fitting protocol. Initial qEEG at RECO Island is typically performed once acute detox is complete and vitals are stable, capturing the early post-acute brain state. A follow-up scan later in the residential program then shows trajectory: which patterns are normalizing, which are persisting, and where targeted intervention is still needed. The comparison between scans is often more clinically informative than any single snapshot.

qEEG findings shape concrete aftercare recommendations. Persistent frontal slow waves at discharge often point patients toward outpatient neurofeedback or continued cognitive rehabilitation work. Patterns suggestive of co-occurring depression, anxiety, ADHD, or PTSD inform the receiving outpatient psychiatrist’s medication choices. A clearly normalizing brain map is reassurance for the patient and family that recovery is producing real biological change — useful at the moment of discharge anxiety. We do not promise specific treatment outcomes from qEEG; we use it as one of several data inputs (bloodwork, symptom scales, clinical assessment) in building the next phase of care.

Yes. qEEG is completely non-invasive and risk-free — the scalp electrodes only record electrical activity; they do not deliver any current, magnetic field, or substance to the brain. The session takes about 45 to 60 minutes including cap fitting, the recording itself runs roughly 20 minutes (eyes-closed and eyes-open conditions), and there is no recovery time afterward. The most common minor inconvenience is washing conductive gel from the hair afterward. Patients in mid-detox or with severe tremor are deferred until they can sit still for the recording window; safety is the gating factor, not the test itself.

qEEG coverage during medically supervised detox and residential addiction treatment varies by carrier and contract. When billed under a substance use disorder diagnosis with a clear treatment-planning rationale, many commercial plans (Aetna, BlueCross BlueShield, Cigna, United, Optum, Magellan, Humana) reimburse partial or full cost. Some plans treat qEEG as investigational outside specific psychiatric indications. Our admissions and billing teams verify coverage in advance and quote any patient responsibility before the scan is performed. In contracted bundled detox per-diems, qEEG is frequently included at no separate cost to the patient.